Myriad Genetics Files New Patent Complaints Over Low-Cost Genetic Tests

SALT LAKE CITY - In the wake of a partial defeat before the U.S. Supreme Court last month in Association for Molecular Pathology v. Myriad Genetics Inc. (No. 12-398, U.S. Sup.), Myriad Genetics Inc. shows no signs of slowing down, levying patent infringement allegations on July 10 against a competitor in Utah federal court (Myriad Genetics Inc. et al. v. Gene By Gene Ltd., No. 13-643, D. Utah.).

Access this news story on®